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Historical background. More than 15 years have passed
since localized epicardial electrical signals beyond ventricu-
lar activation were recorded in dogs with ventricular ar-
rhythmias after experimental myocardial infarction (I) and
subsequently termed "late potentials." These observations
became the basis for catheter and intraoperative electrical
mapping in humans with sustained ventricular tachyarrhyth-
mias following myocardial infarction to enable curative
endocardial resection (2). During the past decade, signal-
averaged surface electrocardiography has demonstrated the
ability to record such late potentials noninvasively. Corre-
lations between late potentials detected on the signal-
averaged electrocardiogram (ECG) and spontaneous or in-
duced sustained ventricular tachyarrhythmias in a variety of
clinical states have been reproducibly confirmed. Thus, late
potentials have been referred to as markers of an electrical
substrate capable of sustaining malignant ventricular ar-
rhythmias.
Concomitantly, a decade of clinical investigations with
administration of various thrombolytic agents during the
evolutionary phase of acute myocardial infarction has
proved fruitful. When administered within several hours
after the onset of symptoms, thrombolytic agents have
demonstrated improvement in the preservation of left ven-
tricular function and survival. Successful reperfusion has
been associated with spontaneous ventricular arrhythmias,
most notably accelerated idioventricular rhythms. De-
creased frequencies of ventricular premature beats have
been reported after successful thrombolytic therapy. How-
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ever, no substantial data have been reported concerning the
impact that coronary artery reperfusion has had on the
occurrence of significant ventricular tachyarrhythmic events
after the early postmyocardial infarction period.
Signal-averaged electrocardiography after myocardial in-
farction. Of all available noninvasive approaches explored
thus far, an abnormal signal-averaged ECG represents the
strongest predictor of a sustained ventricular tachyarrhyth-
mia after myocardial infarction (3-5). The effect of throm-
bolytic therapy on late potentials may provide useful prog-
nostic data regarding future arrhythmic events. In this issue
of the Journal, Turitto and colleagues (6) evaluated the effect
of thrombolytic therapy administered within 6 h of the onset
of myocardial infarction on the signal-averaged ECG. Their
data revealed no significant differences in the presence of
any abnormal signal-averaged variables (evaluated in the
time domain mode) whether analyzed individually or in any
possible combination. This finding held whether or not
infarct-related vessel patency was present.
Thrombolytic therapy and late potentials. Despite their
origin in a well designed study, these findings need to be
interpreted with great caution. True trends were present
with respect to more abnormal quantitative and qualitative
signal-averaged variables in patients who did not receive
thrombolytic therapy or whose coronary angiogram did not
demonstrate patency of the infarct-related vessel. Most
notably, the quantitative root mean square voltage of the
terminal 40 ms of the signal-averaged vector complex was
significantly more abnormal in these patients. This finding
could suggest that the cellular and stromal changes required
for the development of an arrhythmic substrate and late
potentials are lessened with thrombolytic therapy. Because
the left ventricular ejection fraction was higher in patients
receiving thrombolytic agents, the higher root mean square
voltages of the terminal 40 ms and of the entire QRS vector
complex may have reflected preservation of greater myocar-
dial tissue,
Comparative studies of thrombolytic therapy and signal-
averaged electrocardiography. Given that the conclusions of
this report (6) are not conclusive, the contrasting findings
that Gang and colleagues (7) recently reported must also be
looked on with a degree of skepticism. Although Gang and
colleagues compared patients who had successful reperfu-
sion with those who had unsuccessful thrombolytic therapy,
important differences existed that could account for the
different findings. Furthermore, these differences raise is-
sues that need to be resolved:
I. Patients were considered for thrombolytic therapy if
they were seen within 4 h of symptom onset in the study of
Gang et al. (7), whereas enrollment required treatment
within 6 h in the present study. Thus, does the time of
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administration of thrombolytic agents alter the heterogeneity
of myocardial injury and the subsequent recording of late
potentials to different degrees?
2. The thrombolytic agents used were predominantly
urokinase in the present study, whereas Gang et al. used
only recombinant tissue-type plasminogen activator (rt-PA).
Thus, is the development of postinfarction late potentials
somehow related to the thrombolytic agent used?
3. Characteristics of vessel patency also differed between
the two studies: Thrombolysis in Myocardial Infarction
(TIMI) trial grade 2 or better in the present study and TIMI
grade 3 in the study of Gang et al. (7). Thus, one must ask
whether late potential development is at all dependent on the
extent of perfusion and collateral vessel development. To
this end, suggestions have been made that collateral blood
vessels to an infarct-related artery may be more common in
patients with than in those without sustained ventricular
tachycardia (8).
4. As Turitto et al. (6) point out, the optimal time for
recording a signal-averaged ECG is from 48 h to 2 weeks
after myocardial infarction. In their study, the results were
analyzed in terms of signal-averaged ECGs obtained 13 ± 2
days after myocardial infarction, whereas they were ob-
tained within 48 h in the study of Gang et al. (7). This
difference may, in part, explain the discordance of results
between the two studies because reanalysis ofthe previously
reported results of Gang et al. on the basis of signal-averaged
ECGs obtained later has an adverse effect on the study's
statistical significance.
S. Differences in the signal-averaged techniques and def-
initions of abnormal results in the two studies may have
participated in the discrepant results and need to be re-
solved. Many investigators still use the normal values for
signal-averaged ECG variables originally proposed by Sim-
son (3), whereas few have established norms for their patient
populations. Even in the only two comparative studies on
the effect of thrombolytic therapy on signal-averaged record-
ings (6,7), differences in the accepted normal QRS duration
of the vector complex exist. In addition, the precise signal-
averaged variables defining as abnormal ECG differed be-
tween the two studies. Yet even when a signal-averaged
ECG was defined as abnormal on the basis of abnormalities
of all three variables, as in the report of Gang et al. (7), the
present study still falls shy of revealing a statistical differ-
ence associated with infarct vessel patency.
Recommendations for future studies. Thus, as signal-
averaged electrocardiography becomes more widely em-
ployed, absolute criteria should be proposed for abnormal
signal-averaged ECG. Even with the inconsistencies noted,
the clinical implication of signal-averaged electrocardiog-
raphy for risk stratification after myocardial infarction in
patients with nonsustained ventricular tachycardia and in
patients with syncope of unknown etiology has become
widely accepted.
In the present study, no follow-up data are provided with
respect to the development of subsequent malignant ventric-
ular tachyarrhythmias or sudden death. However, if the
incidence of arrhythmic events turns out to be as low as that
in the study of Gang et al. (7) (that is, I of 62 or 1.5% of
patients with an abnormal signal-averaged ECG at 6
months), one must question whether signal-averaged elec-
trocardiography after thrombolytic therapy may lose some
of its predictive ability for a postinfarction arrhythmic event.
Alternatively, the lower incidence could be due to the
relatively preserved left ventricular ejection fractions re-
ported in both studies.
Further studies are needed to evaluate the impact of
thrombolytic therapy on late potentials, both as a marker of
infarct vessel patency and as a marker of future malignant
ventricular tachyarrhythmias. However, such studies should
be large cooperative efforts, like the numerous thrombolytic
trials. Consistent methodologies should be used to reconcile
the discrepancies pointed out here, as well as others that
may not have been mentioned.
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